Key facts
- This page summarizes Jan Stahlberg's Form 4 filing for DiaMedica Therapeutics Inc. (DMAC).
- 7 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Dec 2025, 17:15.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Purchase
Purchase
Purchase
Purchase
Purchase
Purchase
Additional SEC filing notes
Footnote F1
These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.